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5The continuum model of psychosis phenotype
The psychosis syndrome is characterized by the disruption of 
higher mental functions where any basic psychological process 
can be altered (Lemos Giráldez, Fonseca-Pedrero, Paino, & 
Vallina, 2015). Particularly, a heterogeneous combination of 
symptoms such as hallucinatory experiences, delusional ideation, 
disorganized speech and behavior, affective fl attening or loss of 
initiative, as well as social and occupational impairment may 
defi ne this syndrome (Kahn et al., 2015; van Os, Kenis, & Rutten, 
2010). Moreover, defi cits in attention, memory, executive functions, 
and social cognition can be found (Kahn et al., 2015; van Os et al., 
2010). To date, although its etiology is still unknown, psychotic 
syndromes are hypothesized to be the result of a complex interplay 
between genetic and environmental factors. Specifi c clinical 
symptoms or etiopathogenic markers for its precise diagnosis have 
not yet been found (Kahn et al., 2015; van Os et al., 2010). 
Psychotic-spectrum disorders include a series of mental 
disorders such as schizophrenia, schizoaffective disorder, affective 
psychosis, and psychotic disorder induced by substances as well 
as schizoid, schizotypal, and paranoid personality disorders. 
The psychosis syndrome affects about 2-3% of the population 
(Perälä et al., 2007). The onset of symptoms occurs usually in 
late adolescence and begins gradually and progresses over time, 
between two to fi ve years before clinical diagnosis (Fusar-Poli, 
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Abstract Resumen
Background: The psychosis phenotype is distributed along a severity 
continuum that ranges from psychological well-being to full-blown 
psychosis. Schizotypal traits and psychotic-like experiences are considered 
as one of the possible phenotypic indicators of the latent liability for 
psychosis (named schizotypy). This selective review offers a general 
overview and update of trait schizotypy and psychotic like experiences 
during adolescence. Method: The previous literature on schizotypal 
traits  and psychotic like experiences is selectively reviewed. Results: 
We begin with a brief introduction of psychosis syndrome from an 
extended psychosis phenotype framework as well as a brief defi nition of 
trait schizotypy and psychotic-like experiences. We introduce the study 
of these traits and experiences from a developmental perspective, where 
the psychosis proneness-persistence-impairment model is highlighted. 
We provide a selective review of the tools available for assessment these 
constructs from the psychometric high-risk paradigm. We then discuss 
the factorial validity of the studies conducted in adolescents. In addition, 
the links between this set of subclinical traits and experiences and other 
variables gathered from a translational approach are discussed, with the 
aim to establish a nomological network. Conclusions: We conclude by 
considering remaining questions and future directions for the understanding 
of trait schizotypy and psychotic-like experiences during adolescence. 
Key words: Schizotypy, Psychotic-like experiences, Psychosis, Adolescent, 
Schizotypal traits.
Rasgos esquizotípicos y experiencias psicóticas atenuadas en la 
adolescencia: una actualización. Antecedentes: el fenotipo psicótico 
se distribuye a lo largo de un continuo de gravedad. Los rasgos 
esquizotípicos y las experiencias psicóticas atenuadas son considerados 
posibles indicadores fenotípicos de la vulnerabilidad latente a la psicosis 
(denominada esquizotipia). Se ofrece una revisión selectiva referente al 
estudio de los rasgos esquizotípicos y de las experiencias psicotiformes 
durante la adolescencia. Método: la literatura previa sobre la esquizotipia 
y las experiencias psicóticas atenuadas fue revisada. Resultados: se realiza 
una introducción al síndrome de psicosis desde el modelo fenotipo psicótico 
“extendido”, así como una defi nición y delimitación de la esquizotipia 
y las experiencias pseudo-psicóticas. Se introduce el estudio de estas 
experiencias y rasgos desde una perspectiva del desarrollo, y se pone 
énfasis en el modelo propensión-persistencia-deterioro de la psicosis. Se 
revisan las herramientas de medición disponibles para su evaluación desde 
el paradigma de alto riesgo psicométrico y se discute la validez factorial. 
Además, se analizan los nexos de unión entre este conjunto de  experiencias 
psicotiformes y otras variables a partir de un enfoque translacional, con el 
objetivo de establecer una red nomológica. Conclusiones: se comentan 
algunas cuestiones así como direcciones futuras de investigación para la 
comprensión de la esquizotipia y experiencias pseudo-psicóticas durante 
la adolescencia.
Palabras clave: esquizotipia, experiencias psicóticas atenuadas, psicosis, 
adolescentes, rasgos esquizotípicos.
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Carpenter, Woods, & McGlashan, 2014). Psychotic-spectrum 
disorders have a clear impact at personal, educational, family, 
and occupational levels as well as on healthcare costs and societal 
expenditure. For instance, schizophrenia and other psychoses are 
amongst the ten leading causes of disability-adjusted life years in 
the group aged 10-24 years (Gore et al., 2011), representing the 
third most expensive disorders in Europe (Olesen, Gustavsson, 
Svensson, Wittchen, & Jönsson, 2012). 
The psychosis phenotype is distributed along a serenity 
continuum that ranges from psychological well-being to full-blown 
psychosis. For example, hallucinatory experiences and delusional 
ideation are experienced by the general population in the absence 
of mental illness without being necessarily associated with a 
mental disorder, medical condition, or need for care (Linscott 
& van Os, 2013; van Os, Linscott, Myin-Germeys, Delespaul, & 
Krabbendam, 2009). This set of subclinical psychotic experiences 
and traits which do not reach clinical threshold and are distributed 
throughout the general population are usually known as schizotypal 
traits and psychotic-like experiences (PLEs). 
Epidemiological studies and meta-analyses have demonstrated 
that the mean prevalence of PLEs reported in the general 
population is around 5-8% (Linscott & van Os, 2013; McGrath 
et al., 2015; Nuevo et al., 2012). A meta-analysis carried out by 
Linscott and van Os (2013) found 7.2% prevalence and 2.5% mean 
annual incidence. An international study conducted by McGrath 
et al. (2015), using a sample of 31,261 adults from 18 countries, 
found that the average prevalence of 5.8%, 5.2% and 1.3% for 
PLEs, hallucinatory experiences, and delusional experiences, 
respectively. Furthermore, a meta-analysis of PLEs during 
childhood and adolescence conducted by Kelleher et al., (2012), 
found a mean prevalence rate of around 17% in participants 
aged 9 to 12 years, and 7.5% in participants aged 13 to 18 years. 
Similarly, Dolphin et al. (2015) conducted a study using a national 
representative sample of 12-19 year olds from Ireland, in which 
auditory hallucinations were reported by 13.7% of participants, 
visual hallucinations reported by 10.4%, and paranoid thoughts 
reported by 13.1% of the sample. These reports are also consistent 
with data originating from a U.S. representative sample of 7,054 
adolescents, in which Calking et al. (2014) found that between 3.8-
17.6% of the sample endorsed “Defi nitely agree” in some PLEs 
items.
As it can be seen, previous empirical research has demonstrated 
that the frontiers of the psychosis phenotype extend beyond the 
traditional borders proposed by the international classifi cation 
systems (e.g., DSM-5, ICD-10), which offers support to the 
existence of a psychometric continuity between the clinical and 
subclinical psychosis phenotypes (Linscott & van Os, 2013). From 
this continuum, the expression of this extended phenotype would 
fl uctuate from a normal state of functioning, going from subclinical 
psychotic experiences and traits, toward its clinical manifestation 
in the form of certain psychotic-spectrum disorders (Linscott & 
van Os, 2013; van Os et al., 2009). Figure 1 depicts the possible 
architecture of the psychosis phenotype (Fonseca-Pedrero, Paino-
Piñeiro, Lemos-Giráldez, Sierra-Baigrie, & Muñiz, in press a). 
Schizotypal traits and psychotic-like experiences: A tentative 
differentiation
Several authors use the constructs PLEs, schizotypy, 
schizotypal traits, psychosis-proneness, and psychotic experiences 
as interchangeable, even though there is no scientifi c rationale 
or evidence. For instance, recent review studies have shown that 
there is no clear defi nition of PLEs across studies (Lee et al., 
2016). Thus, an operationalization of these phenomenon are 
required, amongst others, to guide this measurement framework, 
to provide the basis for construct validation, to test and validate 
psychosis models, and to differentiate from other related 
constructs. 
First, schizotypy is defi ned as a latent personality organization 
refl ecting a putative liability for psychotic-spectrum disorders 
(Meehl, 1962). It is hypothesized that this diathesis is expressed 
according to a vulnerability continuum that ranges from 
psychological well-being to schizophrenia-spectrum personality 
disorders and full-blown psychosis (Kwapil & Barrantes-Vidal, 
2015). This liability would theoretically be present in about 10% of 
the general population (Meehl, 1962). Recent conceptualizations 
of the schizotypy framework indicate that it provides a unifying 
construct that effi ciently links a broad continuum of clinical and 
subclinical psychosis manifestations (e.g., schizotypal traits, 
PLEs, attenuated psychotic symptoms, basic symptoms), as well as 
“normal” personality variation (Kwapil & Barrantes-Vidal, 2015). 
Thus, schizotypal traits, PLEs, attenuated psychotic symptoms, 
schizotypal personality disorder features, and frank psychotic 
symptoms should be described as indicators of schizotypy 
(Lenzenweger, 2015). Hence, the heterogeneity in the phenotypic 
indicators of psychosis liability shows that it is not necessarily 
isomorphic (Lenzenweger, 2010). In particular, schizotypal 
traits and PLEs are considered as one of the possible phenotypic 
indicators of this diathesis. This liability can be measured 
by genetic, psychometric, laboratory, and clinical indicators 
(Lenzenweger, 2010).
Second, PLEs by defi nition are transitory in nature and tend to 
disappear over time (particular during adolescence) (Linscott & 
van Os, 2013; Debbané et al., 2013). Only a minority percentage of 
Figure 1. Possible architecture of psychosis phenotype across the 
continuum of severity (Fonseca-Pedrero et al., in press a)
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the PLEs reported are persistent over time. Basically, schizotypal 
traits usually are stable in time (trait-like approach), whereas PLEs 
are unstable or a state in nature (symptom approach) (Debbané & 
Barrantes-Vidal, 2015). This is a key issue to differentiate PLEs 
from related constructs, such as schizotypal traits. 
Third, PLEs are commonly referred to as a set of unusual 
perceptual experiences related with the positive dimension of 
the psychosis phenotype, mainly hallucinations and delusional-
like experiences. Although some authors have also included 
the negative (e.g., anhedonia) and depressive dimensions within 
the PLEs construct (based on the Community Assessments of 
Psychic Experiences-42, CAPE-42), previous meta-analyses, 
epidemiologic studies, and factor analyses conducted to date 
are based mainly on the positive dimension (Kelleher, Connor 
et al., 2012; Linscott & van Os, 2013; van Os et al., 2009). This 
issue is also relevant to differentiate PLEs from trait schizotypy. 
The former is defi ned as a set of subtypes of positive psychotic 
experiences, i.e., bizarre experiences, perceptual abnormalities, 
grandiosity, persecutory ideas, that should not be regarded as a 
homogenous entity (Yung et al., 2009), while the latter is defi ned 
as a multidimensional construct that refers basically to anomalies 
across Cognitive-Perceptual (e.g., hallucination, suspiciousness, 
ideas of reference), Interpersonal (e.g., constrict affect, no close 
friends, anhedonia), and Disorganized (e.g., odd behavior and 
speech) dimensions (Debbané & Barrantes-Vidal, 2015). 
Fourth, trait schizotypy and PLEs would be located at some point 
of this severity continuum and could be seen as an “intermediate” 
phenotype, qualitatively similar to the symptomatology found in 
patients with psychosis, but quantitatively less severe, showing a 
lower frequency, severity and persistence, as well as without the 
distress, help-seeking behavior, or/and functional impairment 
(Fusar-Poli et al., 2014; Yung, Stanford et al., 2006). This is also 
a key point to differentiate PLEs and schizotypal traits from 
subclinical psychotic symptoms, frank psychotic symptoms, and 
psychotic-spectrum disorders (see Figure 1). Moreover, these 
factors are relevant to explain and understand the transitions 
between these phenomena across the severity continuum of the 
psychosis phenotype. Although there are blurred boundaries 
between these phenotypic expressions, in fact, the clinical 
impact (e.g., distress, help-seeking behavior, functional decline, 
and functional impairment) is essential in order to differentiate 
these phenomena, and, particularly relevant to predict the risk 
of developing full blown psychotic-spectrum disorders and the 
need for care. To date, it is important to note that the boundaries 
between these phenomenological traits and experiences are fuzzy 
and sometimes unclear. 
Etiological validity of trait schizotypy and psychotic-like 
experiences
 
The principal motivation of the schizotypal traits and PLEs 
constructs is based on the idea of early identifi cation of those 
individuals at risk for psychotic-spectrum disorders prior to 
clinical presentation so as to implement preventive prophylactic 
interventions. Furthermore, the understanding of trait schizotypy 
and PLEs may help elucidate relevant etiological mechanisms and 
protective factors for psychotic-spectrum disorders (Barrantes-
Vidal, Grant, & Kwapil, 2015) in particular, and mental health 
in general. In fact, we would rather suggest that their underlying 
mechanisms surely represent the best possible targets for preventive 
interventions, gathering the potential clinical pathology before it 
develops.
Previous research has shown that both PLEs and schizotypal 
traits may be a valid putative phenotypic liability marker for 
psychosis-spectrum disorders. First, prospective studies carried 
out in adolescents from the general population and those at 
clinical or genetic high risk for psychosis who report PLEs or 
schizotypal traits are at greater probability of psychiatric outcome, 
particularly psychotic-spectrum disorders (Debbané et al., 2015; 
Poulton et al., 2000; Welham et al., 2009; Zammit et al., 2013); 
however, the transition rate to clinical psychosis is low (Kaymaz 
et al., 2012). Moreover, they also increase risk of onset of non-
psychotic mental health disorders (e.g., depression, posttraumatic 
stress disorder, suicide) (Fisher et al., 2013). Thus, PLEs and trait 
schizotypy are not only useful for psychosis-spectrum disorders, 
but also for other psychopathological disorders and symptoms. 
Second, PLEs and schizotypal traits are genetically continuous 
with schizophrenia and are heritable (Linney et al., 2003; Zavos 
et al., 2014). Moreover, they are common in adolescents with 
22q11 Deletion Syndrome (22q11DS), a group of genetic high risk 
for psychosis (Fonseca-Pedrero, Debbané, Schneider, Badoud, 
& Eliez, 2016). Schizotypal traits are present in genetic risk 
populations, such as siblings of probands, where about a third of 
affected individuals develop psychotic spectrum disorders. Third, 
healthy family members of patients with psychosis have higher 
rates of schizotypal traits and PLEs (Kendler et al., 1993). Fourth, 
family-specifi c variation of subclinical psychosis dimensions in 
the general population have been found (Hanssen, Krabbendam, 
Vollema, Delespaul, & Van Os, 2006). Fifth, they share the same 
environmental and demographic risk factors as those found in 
patients with psychosis (e.g., childhood adversities, cannabis use, 
urbanicity) (Linscott & van Os, 2013). Finally, these subclinical 
experiences can be reliable and valid measured by quantitative 
measures (e.g., Fonseca-Pedrero, Gooding, Debbané, & Muñiz, 
2016; Lee et al., 2016). According to a recent review of Fonseca-
Pedrero et al., (in press a) the key points of the PLEs research 
during adolescence are depicted in Table 1.
The phenotypic expression of schizotypy, such as schizotypal 
traits and PLEs, may be considered the behavioral expression of 
increased vulnerability for psychosis. Based on these fi ndings, 
the subclinical psychotic experiences and traits may constitute 
a tentative endophenotype. Moreover, these data lend validity to 
these constructs, as well as offer support to the assumed continuity 
between the subclinical and clinical psychosis phenotype (Kelleher, 
Connor et al., 2012). 
Schizotypal traits and psychotic-like experiences during 
adolescence: A developmental framework
   
Adolescence is an interesting period for the study of 
psychological experiences and traits in mental health in general 
and psychosis-spectrum disorders in particular. First, it is a 
critical developmental stage for the appearance of the fi rst PLEs 
and psychotic symptoms (Fusar-Poli et al., 2014; Linscott & van 
Os, 2013). Second, increasing adjustment problems as well as 
social, motor, and cognition defi cits in adolescents prior to clinical 
diagnosis have been reported (Dickson, Laurens, Cullen, & 
Hodgins, 2012; Fusar-Poli et al., 2012). Third, psychotic-spectrum 
symptoms and disorders that emerge during late adolescence 
or early adulthood seem to develop and originate at earlier 
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stages of development, suggesting the existence of a pathogenic 
developmental process (Zammit et al., 2013). Previous studies 
have shown that the symptoms of psychosis begin around three to 
fi ve years before the fi rst hospitalization (Fusar-Poli et al., 2014; 
Häfner & An Der Heiden, 1999). In addition, it is well known 
that during adolescence and the onset of puberty, a wide diversity 
of maturational, hormonal, brain, cognitive, and social changes 
take place. These “normal” neuromaturational changes could 
become developmental stressors that can increase the risk for the 
emergence of psychotic-spectrum disorders (Walker & Bollini, 
2002). For example, stressful life events or environmental “hits” 
that occur during adolescence, such as traumatic experiences or 
sexual abuse, are associated to a greater vulnerability toward the 
future development of a serious mental disorder (van Os et al., 
2009).
Recently, Debbané and Barrantes-Vidal (2015) have proposed 
a new integrative view of schizotypy within a developmental 
framework. Previously, schizotypy models implicitly recognized 
its developmental nature; however, these authors offer an 
explicitly re-conceptualized view of trait schizotypy from a 
developmental psychopathology perspective, where adolescence 
is a key stage to study. This developmental perspective has a clear 
relevance in understanding how this latent liability for psychosis 
is infl uenced by social learning opportunities, psychosocial stress 
factors, and polygenetic potentiators playing a crucial role, during 
maturation, in the clinical expression of psychotic disorders as 
well as other possible developmental trajectories (e.g., depression, 
bipolar disorder). This idea is clearly convergent with diathesis-
stress models, although focusing on developmental dynamics. 
Debbané and Barrantes-Vidal (2015) situate trait schizotypy in the 
emerging domain of psychosis high-risk research and argue for the 
added value of a transactional, multidimensional examination of 
schizotypy during development. Hence, trait schizotypy would be 
a developmental vehicle towards emerging psychopathology (not 
only for psychotic-spectrum disorders). Moreover, trait schizotypy 
may serve as a distal risk marker for psychosis and could refl ect, 
at the clinical level, the underlying disease process that may be 
unfolding in the development of psychosis.
Several etiological models have been proposed to understand 
the role of PLEs and schizotypal traits and their links with 
(subclinical) psychotic states. The neurodevelopmental models, 
vulnerability-stress models, or the psychosis proneness-
persistence-impairment model, are some good examples. The 
latter is a pragmatic model focused on the interface established 
between environmental and genetic factors from a developmental 
perspective (Cougnard et al., 2007; van Os et al., 2009). This 
developmental schizotypy framework is clearly related to the 
psychosis proneness-persistence-impairment model formulated by 
van Os and colleagues (2009). This heuristic model focuses on the 
interface established between environmental and genetic factors 
to understand the etiopathogenesis of the psychosis syndrome. 
The presence of schizotypal traits or PLEs during adolescence is 
not a necessary or suffi cient condition for the later development 
of a psychotic disorder, although it is true that in a small group of 
adolescents such subclinical experiences and traits may interact 
synergistically or additively with genetic (e.g., family members 
with psychosis), environmental (e.g., trauma, migration, urbanicity, 
cannabis use), and/or psychogical factors (e.g., depression, anxiety, 
avoidance coping), becoming abnormally persistent and clinically 
relevant, leading to the development of clinical psychosis and need 
for care. The Gene-x-Environment interaction combined with the 
presence of other factors, such as, for example, the occurrence, 
severity, persistence, and associated distress of these traits and 
experiences as well as associated social dysfunction and functional 
impairment, would explain the transition to the clinical outcome 
(Kaymaz et al., 2012).
Table 1
Key points in the study of psychotic-like experiences in adolescent population (Fonseca-Pedrero et al., in press a)
– They are distributed throughout the general population, below the clinical threshold, in a severity continuum of psychosis.
– They are not necessarily related with associated distress, help-seeking behavior and/or functional impairment. 
– They may fall within a spectrum of normal developmental experience. 
–  They can have different clinical-psychopathological meaning, depending on the subtypes (e.g., bizarre experiences, perceptual abnormalities, grandiosity, persecutory ideas) and other factors 
(e.g., distress, appraisal, degree preoccupation, and conviction). They should not be regarded as a homogenous entity.
– They can have different developmental trajectories as well as underlying causes.
– They are common in the general population. Mean annual prevalence among adolescents aged 13 to 18 is 7.5%.
– Self-report instruments tend to over-estimate the prevalence.
– They are more frequent in adolescence than in adulthood.
– They are transitory and disappear over time. Persistence rate is about 10-40% of cases. 
– They predict onset of later psychotic disorder (rate 0.5 per year), particularly if persistent.
– They increase risk of onset of non-psychotic mental health disorders (e.g., depression, posttraumatic stress disorder, suicide).
–  They are associate with a wide range of mental health problems (e.g., poor mental health, depressive symptoms, emotional distress, sleep disturbances, suicidal ideation, etc.) as well as multiple 
co-occurring Axis I mental disorders (e.g., anxiety disorder).
–  They are associated with the same demographic, environmental, and genetic risk factors as those found in patients with psychosis (e.g., family history of mental illness, cannabis use, childhood 
trauma, urbanicity, income, age, gender, marital status, etc.).
– They are also associated with neurocognitive defi cits, structural and functional brain abnormalities, and functional dysconnectivity similar to those found in patients with psychosis. 
–  They need to interact synergistically or additively with genetic (e.g., family members with psychosis), demographic (e.g., age, gender), environmental (e.g., trauma, urbanicity, cannabis use), 
and/or psychological factors (e.g., depression, anxiety, distress, avoidance coping, degree of preoccupation and conviction), to become abnormally persistent and clinically relevant, leading to 
the development of clinical psychosis, impairment, and need for care.
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The assessment of trait schizotypy and psychotic-like experiences 
during adolescence
Due to these previous facts, over the past decades, several 
authors and clinicians have tried to predict the onset of clinical 
psychosis based on liability markers or/and preclinical states (e.g., 
schizotypal traits, PLEs, prodromal symptoms, at-risk mental 
states, basic symptoms) that increase the risk for conversion to a 
psychotic state. One of the possible strategies to achieve this goal 
is the reliable and early identifi cation of those individuals at risk 
or with greater predisposition for psychotic-spectrum disorders. 
Prophylactic interventions (e.g., antipsychotics, psychotherapy, 
omega-3 fatty acid) may then be implemented in order to delay, 
ameliorate, or even prevent the onset to frank psychotic features 
and need for care. For example, previous research studies have 
shown that reducing the duration of untreated psychosis with an 
early effective intervention treatment has clear benefi ts at multiple 
levels (e.g., fewer severe symptoms, reduce the transition) and is 
associated with better outcomes (Fusar-Poli et al., 2014; Stafford, 
Jackson, Mayo-Wilson, Morrison, & Kendall, 2013). 
During the last two decades, an increasing interest has steadily 
grown in the reliable and valid identifi cation and screening of 
individuals potentially at risk for psychotic-spectrum disorders 
(e.g., Fonseca-Pedrero, Gooding, Debbané et al., 2016; Mason, 
2015). Precise defi nition and reliable assessment of psychosis 
liability is essential for psychosis-risk screening purposes as well 
as for early detection, in a timely manner, of those individuals 
potentially at risk for psychosis. Moreover, reliable and valid 
measures are needed to capture and to measure this construct in 
operational terms. According to Kwapil and Barrantes-Vidal (2015) 
a clear operationalization of this construct is necessary, among 
others, to guide this measurement framework and provide the basis 
for construct validation. In fact, the psychosis continuum model 
implies the assumption that this set of subclinical experiences and 
traits can be measured in non-clinical populations (van Os et al., 
2009).
The assessment of trait schizotypy and PLEs, in adolescents 
from the general population, by means of interviews and self-
reports falls within the psychometric high-risk approach. This 
paradigm aims to identify, through psychometric tests or based 
on score profi les, adolescents who have a higher probability of 
developing a schizophrenia-spectrum disorder in the future. 
At present, assessment this set of experiences and traits using 
measurement instruments is considered to be a feasible and useful 
strategy which permits a series of advantages with respect to other 
assessment methods. Moreover, it is a noninvasive method of rapid 
application and easier administration, scoring, and interpretation 
(Fonseca-Pedrero, Gooding, Debbané et al., 2016; Mason, 2015). 
To date, there are several measurement instruments available for 
clinicians and researchers to document the presence, frequency, 
and severity of schizotypal traits and PLEs in this age group. 
Table 2 summarizes some of the measurement instruments 
specifi cally developed or used to assess trait schizotypy and 
PLEs in adolescent samples. Clinicians and researchers have 
good measurement instruments available to assess the subclinical 
psychosis phenotype in this age group. However, there is no gold 
standard assessment measure to assess PLEs (Lee et al., 2016) and 
schizotypal traits in adolescents samples. 
The number of available self-reports for trait schizotypy and 
PLEs assessment in adolescents is limited and their psychometric 
characteristics have been barely examined (e.g., Fonseca-Pedrero, 
Paino-Piñeiro et al., in press a; Fonseca-Pedrero, Paino-Piñeiro, 
Lemos-Giráldez, Sierra-Baigrie, & Muñiz, in press b). A reliable 
and valid schizotypy measure is essential to capture this construct 
as well as to measure it in a scientifi c and rigorous manner. 
Several good revisions of this topic have been published elsewhere 
Table 2
Measurement instruments to assess trait schizotypy and psychotic-like experiences in adolescents
Name 
Number 
of items
Format  Reference
Trait schizotypy
Junior Schizotypy Scales (JSS) 95 Yes/No (Rawlings & MacFarlane, 1994)
Multidimensional Schizotypal Traits Questionnaire-Reduced (MSTR-R) 51 Yes/No (DiDuca & Joseph, 1999)
Schizotypy Traits Questionnaire for Children (STA-C) 37 Yes/No (Cyhlarova & Claridge, 2005)
Oviedo Questionnaire for Schizotypy Assessment (ESQUIZO-Q) 51 Likert 5 (Fonseca-Pedrero, Muñiz, Lemos-Giráldez, Paino, & Villazón-García, 2010)
Schizotypal Personality Questionnaire-Child (SPQ-C) 22 Yes/No (Raine et al., 2011)
Melbourne Assessment of Schizotypy in Kids (MASK) 57 Likert 4 (Jones et al., 2015)
Psychotic Like Experiences
Community Assessments of Psychic Experiences-42 (CAPE-42) 42 Likert-4 (Stefanis et al., 2002)
Community Assessments of Psychic Experiences-15 (CAPE-15) 15 Likert-4 (Capra, Kavanagh, Hides, & Scott, 2013)
PRIME Screen (PRIME) 12 Likert-7 (Miller et al., 2004)
PRIME Screen-Revised (PS-R) 12 Likert-7 (Kobayashi et al., 2008)
Specifi c Psychotic Experiences Questionnaire (SPEQ) 63
Yes/no, Likert-4, 
and Likert-6
(Ronald et al., 2014)
Psychosis-like Symptoms Interview (PLIKS-I) 12 Binary (Horwood et al., 2008)
Psychosis-like Symptoms Questionnaire (PLIKS-Q) 12
Likert-3
Conviction and 
past-year frequency
(Zammit, Owen, Evans, Heron, & Lewis, 2011)
Adolescent Psychotic-Like Symptom Screener (APSS) 7 Likert-3 (Kelleher et al., 2011)
Eppenford Schizophrenia Inventory (ESI) 40 Likert-4 (Mass, Haasen, & Borgart, 2005)
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(Fonseca-Pedrero, Gooding, Debbané et al., 2016; Fonseca-
Pedrero, Paino-Piñeiro et al., in press a, in press b; Lee et al., 2016; 
Mason, 2015). The tools used in adolescents need to satisfy some 
criteria, such as: a) specifi cally developed and validated for this 
population; b) adequate psychometric properties (e.g., reliability, 
sources of validity evidence, norms); c) brief; d) easy to answer 
and to administer, and e) have understandable language. Previous 
research have demonstrated that the items used to measure PLEs 
seem to be valid (Kelleher, Harley, Murtagh, & Cannon, 2011) and 
reliable (Linscott & van Os, 2013) in adolescent samples. Thus, 
although new psychometric studies are needed, some of these 
measures can be used in both clinical and research settings. For 
instance, it would be necessary to continue advancing in their 
exhaustive analysis as well as obtain psychometric data supporting 
their predictive validity in representative and random samples of 
adolescents from the general population.
Factorial validity of schizotypal traits and psychotic-like 
experiences during adolescence
 
The understanding of the structure and content of trait 
schizotypy and PLEs in adolescent populations has considerably 
advanced in the last two decades. First of all, the number, 
structure, and content of the dimensions found depends clearly 
on the measurement instrument used, the sample analyzed (e.g., 
country, random vs. convenience sample), the statistical analyses 
conducted (exploratory vs. confi rmatory factor analysis), and level 
of analyses employed (items vs. subscales). Therefore, it must be 
kept in mind that the strict comparison among factorial studies is a 
diffi cult task, which is often hindered by these variables. 
When the factorial structure underlying the trait schizotypy 
tools in this age group is analyzed, it can be observed to be a 
multidimensional construct in nature, phenotypically similar to 
that found in the general adult population as well as in patients 
with psychosis. In previous studies conducted in patients, at 
least three separate dimensions (e.g., positive, negative and 
disorganization symptoms) have been reported (e.g., Liddle, 
1997). Just as schizophrenia is phenotypically heterogeneous, 
encompassing a broad range of emotional, cognitive, perceptual, 
social and behavioral functions, trait schizotypy involves a diverse 
set of traits. 
Recent review of the main factorial studies conducted in 
adolescent populations in the last years have demonstrated that 
the number and content of the schizotypy dimensions ranges from 
three to fi ve factors (Fonseca-Pedrero, et al., in press b). The Positive 
(unusual perceptual experiences, cognitive-perceptual, reality 
distortion) and Negative (anhedonia, interpersonal) dimensions 
have been widely replicated and have been consistently found 
across studies and measures. Furthermore, using the Schizotypal 
Personality Questionnaire (SPQ), its brief version (SPQ-B) 
or child version (SPQ-C), the three-factor model, composed 
by the Cognitive-Perceptual, Interpersonal, and Disorganized 
dimensions, is possibly one of the most replicable and consistent 
models across studies and samples. It has been found in nonclinical, 
outpatient, and 22q11DS adolescents and stable across differing 
statistical techniques and level of analysis (Ericson, Tuvblad, 
Raine, Young-Wolff, & Baker, 2011; Fonseca-Pedrero, Debbané 
et al., 2016; Fonseca-Pedrero, Lemos-Giráldez, Paino, Villazón-
García, & Muñiz, 2009; Raine, Fung, & Lam, 2011). Moreover, 
these dimensions have been shown to be invariant across gender, 
age, and culture (Fossati, Raine, Carretta, Leonardi, & Maffei, 
2003; Ortuño-Sierra et al., 2013). 
To summarize, although there is no unanimous agreement on 
the number of dimensions, the results of the different empirical 
studies taken as a whole allow us to assert that trait schizotypy 
in adolescent populations is composed, at a minimum, of three 
dimensions, namely: Cognitive-Perceptual (Positive, Reality 
Distortion), Interpersonal (Negative Anhedonia), and Disorganized 
(Cognitive Disorganization). Moreover, the SPQ, SPQ-B or SPQ-C 
are the most commonly used measurement instruments for testing 
the multidimensional structure of schizotypal traits as an indirect 
measure of schizotypy during adolescence. Taken together, these 
fi ndings suggest that a similar factorial structure of trait schizotypy 
can be found across samples with different clinical status (e.g., non-
clinical adolescents, adolescents at genetic high risk, adolescents 
at clinical high risk, and patients), which provides support for the 
multidimensional continuum model of psychosis phenotype.
During the last decade, several exploratory and confi rmatory 
factor analyses have been conducted to understand the underlying 
structure of the PLEs measures. The main factorial studies of 
PLEs conducted in adolescents analyzing their structure and 
content discussed in this section focus on the CAPE positive 
dimension (20 items) and CAPE-15 (for a review, Mark & 
Toulopoulou, 2016). For instance, Yung et al., (2009), using the 
positive dimension of the CAPE in a sample of 946 students and 
exploratory factor analysis, four subtypes of PLEs were identifi ed: 
Bizarre experiences, Perceptual abnormalities, Persecutory ideas, 
and Magical thinking. In another study, Yung et al, (2006) also 
reported three dimensions in a clinical sample of adolescents 
(Bizarre experiences, Persecutory ideas, and Magical thinking). 
Armando and colleagues (2010), using 18 items of the positive 
dimension of the CAPE in a sample of adolescents and young 
adults and exploratory factor analysis, found four factors (Bizarre 
experiences, Perceptual abnormalities, Persecutory ideas, and 
Grandiosity). Barrangan et al. (2011), in a community sample 
of 777 Spanish adolescents in a principal component analysis, 
identifi ed four factors of positive symptoms: Persecutory ideation, 
Grandiose thinking, First-rank/Hallucinatory experiences, and 
Self-referential thinking. Wigman et al. (2011), in two large samples 
of adolescents (n= 5,422; n= 2,230) conducting a confi rmatory 
factor analysis, found fi ve underlying dimensions named: 
Hallucinations delusions, Paranoia, Grandiosity, and Paranormal 
beliefs. Recently, Nuñez et al. (2015), testing the factorial structure 
of the CAPE-15 through exploratory structural equation models, 
found that the underlying structure of PLEs was consistent with 
both multidimensional (Persecutory ideation, Bizarre experiences, 
Perceptual abnormalities) and bifactor model. These fi ndings 
are quite relevant as they reveal the existence of a general factor 
underlying the CAPE-15 scores. In addition, these results may 
suggest the possibility of building a one general dimension of the 
PLEs phenomenon.
To summarize, previous factorial studies conducted in 
adolescent populations have reported 5-factor, 4-factor, 3-factor 
models, and a bifactor model. The factor structure of PLEs, 
measured through the CAPE positive dimension, seems to be 
multidimensional. Thus, the number of factors is not replicated 
and consistent across studies; however, it is also true, that there 
are a lot similarities between the structure and contents of the 
factors reported. Although there is no unanimous agreement on 
the number of dimensions, the results of the different empirical 
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studies allow us to assert that PLEs in adolescent populations 
is composed, at a minimum, of three dimensions (Bizarre 
experiences, Delusional ideations, and Perceptual abnormalities) 
(Mark & Toulopoulou, 2016), perhaps collapsed in a bifactor 
model (general PLEs factor). 
Predictive validity and temporal persistence of the schizotypal 
traits and psychotic-like experiences
As mentioned above, prospective studies carried out in 
adolescents from the general population and those at clinical or 
genetic high risk for psychosis who reported PLEs or schizotypal 
traits are at greater probability of psychiatric outcome, particularly 
psychotic-spectrum disorders (Debbané et al., 2015; Domínguez, 
Wichers, Lieb, Wittchen, & van Os, 2011; Kaymaz et al., 2012; 
Poulton et al., 2000; Welham et al., 2009; Zammit et al., 2013). In 
a recent meta-analysis conducted by Kaymaz et al. (2012), it was 
found that the risk of conversion to a clinical psychotic outcome 
in individuals who reported subthreshold psychotic experiences 
(0.56%) was 3.5 times higher than for individuals without psychotic 
experiences (0.16%), particularly if the psychotic experiences 
were severe/persistent. In another follow-up study conducted by 
Zammit et al. (2013), in a sample of 4,724 participants evaluated 
by structured interviews, found that adolescents who at 12 years 
of age reported defi nitive psychotic experiences were at greater 
risk of psychotic disorders at age 18 (Odds Ratio: 12.7; CI 95%: 
6.2-26.1). However, it is equally true that new studies show the 
low specifi city of such experiences, and that their developmental 
trajectory not only is circumscribed to the clinical diagnosis of 
psychosis, but also to other mental disorders (e.g., posttraumatic 
stress disorder) (Fisher et al., 2013), which questions its usefulness 
as a clinical predictor for psychosis (Werbeloff et al., 2012). In this 
sense, it is hypothesized that this set of subclinical experiences 
and traits present at early ages may be useful as a marker of adult 
mental health problems more broadly (Fisher et al., 2013).
Another extremely fascinating issue is to determine the 
degree of continuity and temporal persistence from early and late 
adolescence or from adolescence to adulthood. The analysis of the 
factors and related variables that make these experiences either 
transient, resolving spontaneously, or persistent over time, evolving 
into a psychotic state with functional impairment and need for 
care, is essential for prevention purposes. Previous factorial 
studies have demostrated that the temporal persistence of these 
the temporal persistence of these experiences during adolescence 
is around 10-40% (De Loore et al., 2008; Domínguez et al., 2011; 
Downs, Cullen, Barragan, & Laurens, 2013; Kelleher, Cederlöf, & 
Lichtenstein, 2014; Kelleher, Keeley et al., 2013; Linscott & van 
Os, 2013; van Os et al., 2009). 
For example, Loore et al. (2008) examined a sample of 1,903 
adolescents, and found that after 2 years, PLEs persisted in 28.7% 
of the cases that had reported such experiences at T0 (5.3% of the 
adolescents). Dominguez et al. (2011), in an 8-year-longitudinal 
study conducted in a sample of 845 German adolescents, found 
that of the participants who had been considered as clinical 
cases of psychosis at the end of the assessment period, 38.3% 
had previously presented at least one psychotic experience, and 
19.6% of these cases had been preceded by at least two subclinical 
psychotic experiences. Downs et al. (2013), found that two-thirds 
(66%) of children reported PLEs at baseline and approximately 
two years later, PLEs persisted in 39% of those children. Moreover, 
children with persisting PLEs experienced a greater risk for later 
internalizing and externalizing psychopathology. Finally, Kelleher 
et al. (2013), using a nationally representative prospective cohort 
study of 1,112 adolescents, found persistence rates of 41% (from 
baseline to 3-months follow-up) and 40% (from 3-months follow-
up to 12-months follow-up).
Similar results have been found when schizotypal traits are 
analyzed. Previous research has shown that schizotypal traits are 
highly stable across measures and samples, particularly during 
adolescence (Cella et al., 2013; Debbané, Badoud, Balanzin, & 
Eliez, 2013; Ericson et al., 2011). For instance, Ericson et al. (2011) 
found that the stability of SPQ Child scores between early and 
middle adolescence was r= 0.58, which refl ects moderate stability. 
Similar results have been found in adolescents with 22q11DS 
(Fonseca-Pedrero, Debbané et al., 2016). 
These results are quite important as they show the predictive 
validity of these sets of traits as well as the usefulness of this 
approach. However, empirical evidence indicates that PLEs and 
schizotypal traits may have low predictive value for psychotic 
disorder (rate 0.5 per year particularly if persistent). In particular, 
the vast majority of PLEs are transient, resolve spontaneously, 
disappear over time, and never progress to a clinical psychotic 
disorder. Approximately a third of adolescents who report PLEs 
showed persistence over the follow-up course. In this sense, 
the possible developmental trajectories and pathways toward 
psychotic-spectrum disorders may be heterogeneous. Therefore, 
the simple presence of PLEs or schyzotipal traits at early stages 
of the development does not necessarily implicate the transition 
of a severe mental disorder later in life. Specifi cally, according 
to the psychosis proneness-persistence-impairment model, these 
subclinical experiences and traits can interact synergetically or 
additively with other sociodemographic, environmental, genetic 
and/or psychological factors to surpass the subclinical threshold 
and evolve into a psychotic disorder and need for care (Cougnard 
et al., 2007; van Os et al., 2009).
Building a nomological network of trait schizotypy and psychotic-
like experiences: A translational approach
Much research and clinical work has been conducted over 
the past decade to understand the link between PLEs, trait 
schizotypy, and psychosis. There has been an accumulation of data 
examining the association between psychotic-spectrum disorders 
with subclinical psychotic experiences and traits in the general 
population (Cohen, Mohr, Ettinger, Chan, & Park, 2015; Ettinger, 
Meyhöfer, Steffens, Wagner, & Koutsouleris, 2014; Nelson, Seal, 
Pantelis, & Phillips, 2013). In the last decade, validity evidences 
have been gathered from many levels of analysis (e.g., genetic, 
brain, physiology, cognition, and behaviour). This previous 
extensive empirical research conducted in the schizotypy (liability 
to psychosis) arena is essential to building a strong scientifi c model 
(to be tested), not only based on its relevance as a liability marker 
or its role in understanding etiological mechanisms for psychosis, 
but also in relation with other constructs from multiple levels of 
analyses and unit of analysis (e.g., genetics, cells, brain, cognitive, 
behavioral). Due to the extensive research available in this section, 
only some levels of analysis will be revised.
Paul E. Meehl is not only an outstanding scientist for his 
schizotypy work, but also for positing the concept of a nomological 
network, working together with Lee Cronbach (Cronbach & Meehl, 
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1955). This net is essential to schizotypy construct validation and 
will be a relevant endeavor for schizotypy in the coming years. In 
brief, a nomological network for schizotypy research is needed 
to: (a) have a clear representation and operationalization of the 
latent construct (allowing it to be measured); (b) establish their 
observable manifestations; and (c) set their interrelationships 
with other constructs (related or not); that is, the links between 
theoretical constructs that can be measured. In this regard, the 
schizotypy construct should be measured by several indicators 
(e.g., genetic, psychometric, laboratory, and clinical indicators) 
(Lenzenweger, 2010) and several units of analysis following the 
guidelines of the Research Domain Criteria (RDoC) (Insel et al., 
2010) (see Figure 2). The schizotypy nomological network is an 
ongoing process based on empirical research. 
At the genetic level, for example, recent studies have 
demonstrated the genetic and environmental infl uences on PLEs 
as a quantitative phenotype (Ronald, 2015). These kinds of 
empirical studies have been addressed recently. Thus, although 
we are at an early stage, between 15 and 59% of variance in PLEs 
is explained by additive genetic effects in a community sample of 
adolescents (Zavos et al., 2014). However, a twin study has found 
less heritability estimates in the subtypes of PLEs (Sieradzka 
et al., 2015). Moreover, molecular genetic studies have found 
some tentative evidence that genome-wide signifi cant variants 
associated with schizophrenia also account for variance in PLEs 
in the community; nevertheless, it is also true, that some negative 
evidences or little support for the hypothesis that psychotic 
experiences in community based samples of adolescents share a 
comparable genetic architecture to schizophrenia, have also been 
found (Sieradzka et al., 2014; Zammit et al., 2014).
At the anatomical and physiological levels, individuals 
who report PLEs compared to those who do not report these, 
show structural (Satterthwaite et al., 2016) and functional brain 
abnormalities (Dahoun et al., 2011; Wolf et al., 2015), functional 
disconnectivity (Satterthwaite et al., 2015), and a reduced 
amplitude of the P300 (event-related potentials) (Rawdon et al., 
2013) similar to those found in patients with psychosis.
At the cognitive and behavioral levels, adolescents who report 
PLEs show neurocognitive (Kelleher, Clarke, Rawdon, Murphy, & 
Cannon, 2013), theory of mind (Barragan, Laurens, Blas Navarro, 
& Obiols, 2011), social cognition defi cits (e.g., facial emotion 
recognition) (Roddy et al., 2012) and a developmental cognitive 
delay (Gur et al., 2014). Moreover, these participants may report, 
amongst others, low self-esteem, low optimism, school misconduct, 
high avoidance coping (Dolphin et al., 2015), low prosocial skills, 
poorer peer and familiar functioning (Núñez et al., 2015; Yung et 
al., 2009), and social withdrawal (Núñez et al., 2015).
At the psychopathological and clinical levels, PLEs are 
associated with a wide range of mental health problems, such 
as depressive symptoms (Armando et al., 2010; Barragan, 
Laurens, Blas Navarro et al., 2011; Yung et al., 2009), distress 
(Armando et al., 2010), stress and anxiety (Núñez et al., 2015), 
emotional and behavioral problems (Wigman et al., 2011), sleep 
disturbances (Lee, Cho, Cho, Jang, & Kim, 2012), childhood 
trauma and bullying (Kelleher et al., 2008; Kelleher, Keeley et 
al., 2013), suicidal behavior (ideation, attempts) (Kelleher et al., 
2014; Kelleher, Corcoran et al., 2013), cannabis use (Hides et al., 
2009), and increased risk for multiple co-occurring Axis I mental 
disorders (Kelleher, Keeley et al., 2012).
Similar results have been found when schizotypal traits are 
studied, showing clear lines of overlap between trait schizotypy and 
PLEs across these levels of analysis. Previous research has shown 
that adolescents who report schizotypal traits also present subtle 
brain function, psychophysiological, motor, neurocognitive, social 
cognition, emotional, affective, behavioral, and/or social defi cits 
(Ettinger et al., 2014). For instance, adolescents who scored high 
on schizotypal measures showed, amongst others, more depressive 
symptoms, maladaptive personality traits, obsessive compulsive 
symptoms, behavioral problems, suicidal ideation, poorer social 
functioning, prosocial skills, refl ective functioning, and quality 
of life as well as neurocognitive defi cits in comparison with those 
who scored low (Barrantes-Vidal et al., 2002; Debbané et al., 2013; 
Debbane et al., 2014; Ettinger et al., 2014; Fonseca-Pedrero, Ortuño-
Sierra, Paino, Lemos Giraldez, & Muñiz, 2015; Fonseca-Pedrero, 
Paino, Lemos-Giráldez, & Muñiz, 2011; Raine et al., 2011). 
In overall terms, previous research has shown that adolescents 
who report PLEs and schizotypal traits also present subtle brain 
function, psychophysiological, motor, neurocognitive, social 
cognition, emotional, affective, behavioral, and/or social defi cits 
similar to those found in patients with psychosis. Thus, research 
PLEs and schizotypal traits in adolescents may represent a valuable 
population to study the etiology of psychosis and related conditions 
and lend validity to these constructs, as well as offer support to 
the assumed etiological continuity between the subclinical and 
clinical psychosis phenotype (Kelleher & Cannon, 2011; Linscott 
& van Os, 2013; van Os et al., 2009). 
Gaps in knowledge
  
The study of subclinical psychotic experiences and traits during 
adolescence is a fi eld that is in clear expansion where several 
extremely interesting questions remain unsolved. 
First, based on previous reviews (Lee et al., 2016), in the new 
generation of studies, it is relevant to build an operative defi nition 
of this set of experiences and traits as well as to differentiate related 
constructs. For instance, previous research studies have shown 
that schizotypal traits, PLEs, and self-reported clinical high risk 
symptoms are moderately associated but can be differentiated in 
community derived samples of adolescents (Barrantes-Vidal et al., 
2013; Fonseca-Pedrero, Gooding, Ortuño-Sierra, & Paino, 2016). 
An operationalization is essential to measure these phenomena in 
a reliable and valid manner as well as to develop testable models.
Figure 2. Possible network model of schizotypy based on the units of 
analysis of the Research Domain Criteria
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Second, the role of PLEs and trait schizotypy in the prediction 
of psychotic disorders and non-psychotic disorders (e.g., 
depression) should continue to be explored in greater depth through 
independent longitudinal studies in both non-clinical adolescents 
and participants potentially at high risk for psychosis (e.g., genetic 
high risk, ultra-high risk). For instance, further longitudinal 
studies are required to examine the extent to which schizotypal 
traits (e.g., Cognitive-Perceptual, Interpersonal, and Disorganized 
dimensions) or PLEs (Bizarre experiences, Delusional ideations, 
and Perceptual abnormalities) could contribute to improving the 
prediction of conversion to psychotic-spectrum disorders. In order 
to improve the predictive validity, the combination of multiple 
high-risk approaches (e.g., clinical, genetic, and psychometric), 
liability markers and risk factors (e.g., genetic and environmental), 
in a close-in and multi-step strategy, may improve our predictive 
power of those individuals theoretically at high risk and develop 
prevention strategies. Thus, new algorithms to improve sensitivity 
and specifi city indicators from an integrated psychobiological 
perspective are needed. The new studies have to facilitate the 
integration of early and late risk mental states as well as different 
etiological models within a developmental framework.
Third, the study of the extended psychosis phenotype from 
multiple levels of analyses and multiple indicators is essential in 
the new era of studies. For instance, combining genes, molecules, 
cells, circuits, physiology, behaviors, and self-report levels of 
analyses allows us to better understand psychotic-spectrum 
disorders as well as to examine which factors and level analyses 
could determine the transition to a psychotic state in high-risk 
participants. Moreover, new studies would be integrated following 
the guidelines of the RDoC. RDoC is a novel research framework 
to promote new ways of studying mental disorders. It integrates 
many levels of information, from genomics to self-reports, to better 
understand basic dimensions of functioning underlying the full 
range of human behavior and processes, from normal to abnormal. 
Thus, we encourage a translational approach. Along these lines, 
Ford et al. (2014), have explored how hallucinations might be 
studied within the RDoC framework. Building a scientifi c model 
based on the translational approach is required. 
Fourth, with regard to the use of measurement instruments in 
this age group, their psychometric properties have to be tested in 
representative samples of adolescents from the general population 
as well as high risk groups, being particularly relevant to gathering 
new evidences of their validity in independent longitudinal studies. 
To this end, new measurement approaches and psychometric 
procedures such as McDonald’s omega, item response theory, 
computerized adaptive testing, differential item functioning, 
new structural equation models, or network analysis have to be 
incorporated in this fi eld. These methodological advances may 
better capture the complexity and heterogeneity of the schizotypy 
phenotype. For instance, new methodological designs such 
as the experience sampling method (ESM) have to be added 
progressively in schizotypy research. ESM is a structured diary 
technique assessing cognition, affect, symptoms, and contextual 
factors in the real context (Oorschot, Kwapil, Delespaul, & Myin-
Germeys, 2009). ESM offers several advantages to traditional 
cross-sectional procedures, for instance, ESM: (a) repeatedly 
assesses individuals in their daily environment, enhancing 
ecological validity, (b) assesses the participants’ experiences at 
the time of the signal, minimizing retrospective bias, (c) allows 
for an examination of the context of individuals’ experiences, and 
(d) captures the interactional nature of the vulnerability-stress 
model by analyzing dynamic person-environment interactions. 
Advances in the fi eld of measurement open up new horizons for 
the assessment and the understanding of the structure and content 
of these set of experiences and traits.
Fifth, given the public health relevance of mental health 
during adolescence and its possible impact during adulthood, a 
new interesting line of research would be to use PLEs and trait 
schizotypy (or other phenotypic indicators of psychosis) within a 
prevention approach. PLEs and schizotypal traits, as an index of 
mental health status, should be used for screening purposes in a 
mental health worldwide strategy. Moreover, during the last few 
decades most of the researchers have focused their lines of research 
on psychosis risk factors, liability markers, endophenotypes, at risk 
mental states, etc., however, few studies have been conducted to 
analyze the strengths of these individuals. The study of protective 
and resilience factors may help us to: a) fi nd new clues to delay, 
ameliorate, or even prevent the onset to frank psychotic symptoms; 
b) elucidate relevant etiological mechanisms for mental health 
problems; and b) expand to other research areas of interest and 
move away from a “non-pathological” view of these subclinical 
experiences and traits.
Finally, big data projects and sharing data across international 
groups would be desirable. Hence, the International Lemanic 
Workshop on Schizotypy Research (Geneva, December, 
2013) set the foundations for future collaborative research 
through the creation of the Consortium for International 
Schizotypy Research (CISR) (Debbané & Mohr, 2015). 
Conclusions
Psychotic-spectrum disorders have an impact at multiple levels 
and a clear societal and health expenditure. The public burden 
caused by these severe mental disorders is clear, thus the early 
identifi cation of adolescents potentially at risk for psychotic-
spectrum disorders in order to conduct prophylactic treatments 
may improve outcome. Furthermore, the implementation of 
preventive approaches in adolescent mental health in general, and 
in psychotic-spectrum phenomena in particular, is necessary. 
Psychotic symptoms occur in continuous gradation from severe 
symptoms to those seen in milder forms of disorders and further 
into personality traits and psychological experiences distributed 
in the general population. Subclinical psychotic experiences and 
traits which do not reach the clinical threshold for psychosis, 
that are not related with associated distress, help-seeking 
behavior and/or functional impairment, and that are continuously 
distributed across the general population, are known as PLEs or 
schizotypal traits. Although, to date, is diffi cult to establish a clear 
differentiation between both constructs, schizotypal traits and 
PLEs are considered as amongst many of the possible phenotypic 
indicators of the psychosis liability (named schizotypy), where 
schizotypal traits are stable whereas PLEs are unstable or a state 
in nature (Debbané & Barrantes-Vidal, 2015). In fact, schizotypal 
trait are commonly refers as a multidimensional construct, whereas 
PLEs are referred as positive dimension of psychosis phenotype.
The study of these traits and experiences during adolescence 
and their relationship to the subsequent risk for psychotic-
spectrum disorders and other mental health problems has become 
an area of interest within the current scientifi c research fi eld. 
The idea of early detection and prevention of those adolescents 
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potentially at risk for psychosis to mitigate the possible impact of 
the illness on many levels (e.g., personal, familiar, occupational) 
as well as to delay, ameliorate, or even prevent the onset to frank 
psychotic symptoms, has exponentially increased the number of 
studies on subclinical psychotic experiences. Moreover, it opens 
the possibility of examining and understanding risk markers, 
protective factors, and etiological mechanisms of psychotic-
spectrum disorders prior to the clinical expression of the clinical 
disorder. 
Epidemiological studies have demonstrated that this set of 
experiences and traits are quite common during adolescence and 
may fall within a spectrum of “normal” developmental experience. 
In most of the cases disappear over time and never progress to a 
clinical disorder. PLEs and schizotypal traits may have different 
clinical-psychopathological meanings, depending on the subtypes 
and dimensions as well as other factors (e.g., associated distress, 
appraisal, degree preoccupation, and conviction). They need to 
interact synergistically or additively with genetic, demographic, 
environmental, and/or psychological factors to become abnormally 
persistent and clinically relevant, leading to the development of 
clinical psychosis, impairment, and need for care.
Clinicians and researchers have good measurement instruments 
available to assess the risk for psychosis during adolescence. There 
are several measurement instruments available for clinicians 
and researchers to document the presence, frequency, severity, 
trajectory, and associated distress of subclinical psychotic 
experiences and schizotypal traits in this age group. To date, the 
psychometric properties of PLEs and trait schizotypy tools used in 
adolescent populations are adequate for their use in both clinical 
and research settings. The results of the factorial studies allow us 
to assert that PLEs in adolescent populations is composed, at a 
minimum, of three dimensions (Bizarre experiences, Delusional 
ideations, and Perceptual abnormalities), perhaps collapsed into 
a general PLEs dimension. For its part, the factor structure of 
trait schizotypy is essentially multidimensional. Although there 
is no unanimous agreement on the number of dimensions, the 
results of the different empirical studies allow us to assert that 
schizotypy in adolescent populations is composed, at a minimum, 
of three dimensions (Cognitive-Perceptual, Interpersonal, and 
Disorganized). 
There is evidence that PLEs and trait schizotypy may be valid 
putative phenotypic liability markers for psychotic-spectrum 
disorders. This set of non-clinical experiences and traits predicts 
onset of later psychotic disorders (particularly if persistent) and the 
increased risk of onset of non-psychotic mental health disorders. 
Moreover, PLEs and schizotypal traits are associated with the 
same demographic, environmental, and genetic risk factors as 
those found in patients with psychosis. In addition, non-clinical 
adolescents who reported PLEs have demonstrated a wide range 
of mental health problems as well as neurocognitive defi cits, 
structural and functional brain abnormalities, and functional 
disconnectivity, similar to those found in patients with psychosis 
and high risk samples. These fi ndings support the notion of 
phenomenological, temporal, and etiological assumed continuity 
between the subclinical and clinical psychosis phenotype and lend 
validity to the PLEs and schizotypy constructs. 
There is no doubt that in the study of subclinical psychotic 
experiences and traits in adolescents there are still many pieces of 
the puzzle to be solved, making it an extremely interesting fi eld in 
expansion that yet has a fascinating future in store.
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